Stock & Company Details
Insulet Corporation $PODD
Price:
N/A
N/A
69M
$9.9B
52 Week High:
N/A
10 Day Average Volume:
N/A
27.15
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
PODD technical indicators
Latest Insulet Corporation (PODD) indicator readings as of 2026-08-28.
PODD's 14-day RSI is 45.2, in neutral territory. At $145.13 it is trading 32.4% below its 200-day moving average of $214.77, and below its 50-day average of $154.08. Price sits in the middle of its Bollinger Bands ($129.96 to $162.77). ADX reads 18.0, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.
Finance Bot
Ask your questions
Start by typing a question below.
